Literature DB >> 12835302

Double stranded RNA virus in South African Trichomonas vaginalis isolates.

B Weber1, T M Mapeka, M A Maahlo, A A Hoosen.   

Abstract

AIMS: To screen Trichomonas vaginalis isolates from South Africa for the presence of a small double stranded RNA virus designated T vaginalis virus (TVV).
METHODS: TVV was detected by simultaneous extraction of DNA and RNA, and its presence confirmed by electron microscopy and nuclease digestions.
RESULTS: TVV was detected in 59 of 72 (81.9%) isolates.
CONCLUSIONS: These results indicate a possible higher infection rate of South African T vaginalis isolates by the double stranded RNA virus than has been reported for isolates elsewhere.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835302      PMCID: PMC1770003          DOI: 10.1136/jcp.56.7.542

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Simultaneous extraction of DNA and RNA from nuclease-rich pathogenic protozoan Trichomonas vaginalis.

Authors:  C F Chou; J H Tai
Journal:  Biotechniques       Date:  1996-05       Impact factor: 1.993

2.  Trichomonas vaginalis and amplification of HIV-1 transmission.

Authors:  F Sorvillo; P Kerndt
Journal:  Lancet       Date:  1998-01-17       Impact factor: 79.321

3.  Sexually transmitted pathogens in acute pelvic inflammatory disease.

Authors:  A A Hoosen; D J Quinlan; J Moodley; A B Kharsany; J van den Ende
Journal:  S Afr Med J       Date:  1989-09-16

4.  Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates.

Authors:  L J Snipes; P M Gamard; E M Narcisi; C B Beard; T Lehmann; W E Secor
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

5.  Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads
Journal:  Sex Transm Dis       Date:  1997-07       Impact factor: 2.830

6.  Characterization of trichomonad species and strains by PCR fingerprinting.

Authors:  S Vanácová; J Tachezy; J Kulda; J Flegr
Journal:  J Eukaryot Microbiol       Date:  1997 Nov-Dec       Impact factor: 3.346

7.  Characterization of Trichomonas vaginalis virus proteins in the pathogenic protozoan T. vaginalis.

Authors:  H W Liu; Y D Chu; J H Tai
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

8.  The double-stranded RNA in Trichomonas vaginalis may originate from virus-like particles.

Authors:  A L Wang; C C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

9.  Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies.

Authors:  Z F Zhang; C B Begg
Journal:  Int J Epidemiol       Date:  1994-08       Impact factor: 7.196

10.  Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus.

Authors:  A Wang; C C Wang; J F Alderete
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

  10 in total
  12 in total

Review 1.  Trichomoniasis.

Authors:  Jane R Schwebke; Donald Burgess
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Trichomonasvirus: a new genus of protozoan viruses in the family Totiviridae.

Authors:  Russell P Goodman; Said A Ghabrial; Raina N Fichorova; Max L Nibert
Journal:  Arch Virol       Date:  2010-10-26       Impact factor: 2.574

3.  Clinical isolates of Trichomonas vaginalis concurrently infected by strains of up to four Trichomonasvirus species (Family Totiviridae).

Authors:  Russell P Goodman; Taylor S Freret; Tomasz Kula; Alexander M Geller; Megan W T Talkington; Vanessa Tang-Fernandez; Olimpia Suciu; Aleksander A Demidenko; Said A Ghabrial; David H Beach; Bibhuti N Singh; Raina N Fichorova; Max L Nibert
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma.

Authors:  Raina Fichorova; Jorge Fraga; Paola Rappelli; Pier Luigi Fiori
Journal:  Res Microbiol       Date:  2017-03-31       Impact factor: 3.992

5.  Molecular characterization of double-stranded RNA virus in Trichomonas vaginalis Egyptian isolates and its association with pathogenicity.

Authors:  Eman K El-Gayar; Amira B Mokhtar; Wael A Hassan
Journal:  Parasitol Res       Date:  2016-06-17       Impact factor: 2.289

6.  Endobiont viruses sensed by the human host - beyond conventional antiparasitic therapy.

Authors:  Raina N Fichorova; Yujin Lee; Hidemi S Yamamoto; Yuko Takagi; Gary R Hayes; Russell P Goodman; Xenia Chepa-Lotrea; Olivia R Buck; Ryan Murray; Tomasz Kula; David H Beach; Bibhuti N Singh; Max L Nibert
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  Structure of a protozoan virus from the human genitourinary parasite Trichomonas vaginalis.

Authors:  Kristin N Parent; Yuko Takagi; Giovanni Cardone; Norman H Olson; Maria Ericsson; May Yang; Yujin Lee; John M Asara; Raina N Fichorova; Timothy S Baker; Max L Nibert
Journal:  MBio       Date:  2013-04-02       Impact factor: 7.867

8.  Molecular typing of Trichomonas vaginalis isolates by actin gene sequence analysis and carriage of T. vaginalis viruses.

Authors:  Simon C Masha; Piet Cools; Tania Crucitti; Eduard J Sanders; Mario Vaneechoutte
Journal:  Parasit Vectors       Date:  2017-10-30       Impact factor: 3.876

Review 9.  Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?

Authors:  Camila Braz Menezes; Amanda Piccoli Frasson; Tiana Tasca
Journal:  Microb Cell       Date:  2016-06-27

10.  Double-Stranded RNA Viral Infection in Tehran Trichomonas vaginalis Isolates.

Authors:  S Heidary; M Bandehpour; Z Valadkhani; Sj Seyyed-Tabaee; A Haghighi; Ar Abadi; B Kazemi
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.